Related Experiment Video
Updated: Mar 6, 2026

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.5K
Inpatient Continuous Glucose Monitoring and Glycemic Outcomes
David L Levitt1, Kristi D Silver1, Elias K Spanakis1,2
11 Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, MD, USA.
Journal of Diabetes Science and Technology
|March 15, 2017
Summary
Continuous glucose monitoring (CGM) improves diabetes care by detecting glucose highs and lows. This review examines inpatient CGM
Area of Science:
- Endocrinology
- Diabetes Management
- Medical Devices
Background:
- Continuous glucose monitoring (CGM) is standard for outpatient diabetes management, offering real-time glucose data.
- Historically, inpatient CGM was not recommended due to unknown efficacy and safety.
- Recent studies assess inpatient CGM accuracy, but glycemic outcome data remain limited.
Purpose of the Study:
- To review inpatient continuous glucose monitoring (CGM) glycemic outcomes in both non-intensive care unit (non-ICU) and ICU settings.
- To highlight the need for more research on CGM in hospitalized patients, particularly those with type 1 diabetes mellitus.
Main Methods:
- Review of existing studies on inpatient CGM accuracy and reliability.
- Analysis of glycemic outcome data from non-ICU and ICU settings.
- Focus on studies involving hospitalized patients with diabetes.
Main Results:
- In non-ICU settings, retrospective data suggest CGM increases hypoglycemia detection.
- In the ICU, evidence is inconsistent regarding CGM's impact on glycemic outcomes.
- Limited research specifically addresses hospitalized patients with type 1 diabetes mellitus.
Conclusions:
- Inpatient CGM shows promise for improved hypoglycemia detection, especially in non-ICU settings.
- Further research is needed to establish the benefits of inpatient CGM on glycemic outcomes in both ICU and non-ICU environments.
- Hospitalized patients with type 1 diabetes mellitus represent a key population for future inpatient CGM research.
Related Concept Videos
Hypoglycemia and Glucagon
1.1K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.1K
Diabetes Mellitus: Type 2 and Gestational
5.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.3K
Diabetes: Management and Pharmacotherapy
1.2K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.2K
Pulse rhythm
1.5K
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
1.5K
Oral Hypoglycemic Agents: Glinides
780
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
780
Glucose Homeostasis: Regulation of Blood Glucose
4.9K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
4.9K

